EOLS Stock Price | Evolus Inc P/E, Revenue, EPS, & Forecasts

Evolus Inc • EOLS

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Evolus Inc

Ticker

EOLS

Trading on

NASDAQ

ISIN

US30052C1071

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

CEO

David Moatazedi

Headquarters

520 Newport Center Drive, Newport Beach, CA, United States, 92660

Employees

329

Website

evolus.com

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Metrics

BasicAdvanced

Market cap

$478M

P/E ratio

EPS

-$0.90

Dividend Yield

0.00%

Beta

0.88

Forward P/E ratio

20.83

EBIDTA

$-31.4M

Ex dividend date

Price & volume

Market cap

$478M

Average daily volume

1.7M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

20.83

PEG ratio

Trailing P/E

Price to sales

1.67

Price to book

53.71

Earnings

EPS

-$0.90

EPS estimate (current quarter)

-$0.18

EPS estimate (next quarter)

$0.08

EBITDA

$-31.4M

Revenues (TTM)

$286M

Revenues per share (TTM)

$4.46

Technicals

Beta

0.88

52-week High

$17.12

52-week Low

$5.71

50-day moving average

$6.64

200-day moving average

$9.61

Short ratio

13.5

Short %

20.88%

Management effectiveness

ROE (TTM)

-18,729.61%

ROA (TTM)

-10.60%

Profit margin

-20.49%

Gross profit margin

$190M

Operating margin

-14.74%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

12.90%

Share stats

Outstanding Shares

64.8M

Float

50.7M

Insiders %

11.95%

Institutions %

91.17%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 7 analysts.

Average price target

$18.67

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$0.01

$0.02

-37.67%

Q4 • 24Missed

-$0.17

-$0.10

-70.00%

Q1 • 25Missed

-$0.27

-$0.10

-170.00%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$69.4M

$-17.1M

-24.70%

Q2 • 25

$69M

$-15.7M

-22.82%

Q3 • 25

-0.61%

-8.20%

-7.64%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$229M

$247M

108.15%

Q2 • 25

$219M

$248M

113.13%

Q3 • 25

-4.29%

0.12%

4.61%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-24.8M

$-2.3M

$20.7M

$-25.5M

Q2 • 25

$-39.5M

$-2.2M

$18.9M

$-41.1M

Q3 • 25

59.17%

-4.81%

-8.58%

61.32%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Evolus Inc share?

Evolus Inc shares are currently traded for undefined per share.

How many shares does Evolus Inc have?

Evolus Inc currently has 64.8M shares.

Does Evolus Inc pay dividends?

No, Evolus Inc doesn't pay dividends.

What is Evolus Inc 52 week high?

Evolus Inc 52 week high is $17.12.

What is Evolus Inc 52 week low?

Evolus Inc 52 week low is $5.71.

What is the 200-day moving average of Evolus Inc?

Evolus Inc 200-day moving average is $9.61.

Who is Evolus Inc CEO?

The CEO of Evolus Inc is David Moatazedi.

How many employees Evolus Inc has?

Evolus Inc has 329 employees.

What is the market cap of Evolus Inc?

The market cap of Evolus Inc is $478M.

What is the P/E of Evolus Inc?

The current P/E of Evolus Inc is null.

What is the EPS of Evolus Inc?

The EPS of Evolus Inc is -$0.90.

What is the PEG Ratio of Evolus Inc?

The PEG Ratio of Evolus Inc is null.

What do analysts say about Evolus Inc?

According to the analysts Evolus Inc is considered a buy.